Leerink Partners Initiates Coverage On Tenaya Therapeutics With Outperform Rating, Announces Price Target of $7
Leerink Partners Initiates Coverage On Tenaya Therapeutics With Outperform Rating, Announces Price Target of $7
Leerink Partners以跑赢大盘的评级启动对Tenaya Therapeutics的报道,宣布目标股价为7美元
Leerink Partners analyst Mani Foroohar initiates coverage on Tenaya Therapeutics (NASDAQ:TNYA) with a Outperform rating and announces Price Target of $7.
Leerink Partners分析师玛尼·福鲁哈尔以跑赢大盘的评级开始对Tenaya Therapeutics(纳斯达克股票代码:TNYA)进行报道,并宣布目标股价为7美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。